EnglishBlitz

TOEIC Link Medical Devices and Diagnostics Vocabulary: The Regulated-Lifecycle Cluster That Drives Reading Part 6 in the MedTech Vertical

The TOEIC Link medical-devices-and-diagnostics vocabulary cluster, organized by regulated product lifecycle from concept through pre-market submission through post-market surveillance, the collocations ETS recycles, and the drills that move the cluster from passive recognition to productive command.

EnglishBlitz Editorial Team·

TOEIC Link Medical Devices and Diagnostics Vocabulary: The Regulated-Lifecycle Cluster That Drives Reading Part 6 in the MedTech Vertical

Medical devices and in-vitro diagnostics are one of the densest regulated verticals on TOEIC Link. The Part 6 booklet very often carries an email between a quality-assurance manager and a regulatory-affairs lead, a memo from a clinical-affairs director to a notified body, a notification from a post-market-surveillance team to a distributor in an EU member state, or a field-safety notice from a manufacturer to a hospital biomedical-engineering department. The vocabulary that runs these passages is bounded by the regulated product lifecycle — design control, risk management, pre-market submission, manufacturing, post-market surveillance, recall — and once that lifecycle is internalized, the words follow.

This article is the focused TOEIC Link medical-devices-and-diagnostics vocabulary cluster, organized by regulated lifecycle stage because that is the structure ETS uses to build the items. The lifecycle runs from concept and design control through risk management through pre-market submission through manufacturing and quality system through post-market surveillance through field actions and recall, and each stage carries its own dense collocation network.

Why medical-devices-and-diagnostics vocabulary matters on TOEIC Link

The medical-devices register surfaces on TOEIC Link more often than most candidates expect, for three structural reasons.

Reason 1 — medical-device passages are operationally specific and self-contained. A two-paragraph email about a 510(k) submission gap, a EU MDR technical-documentation update, a CAPA closure, a post-market-clinical-follow-up plan, or a field-safety corrective action fits the Part 6 format perfectly. The operational specificity gives the passage tested anchor points without requiring background knowledge.

Reason 2 — the cluster is collocation-dense. A single medical-device email must reference design-control deliverables, risk-management outputs, regulatory submissions, manufacturing controls, and post-market vigilance — each a tight collocation set. ETS tests these as units, not as isolated words.

Reason 3 — medical-devices vocabulary is cross-pollinated with other tested registers. Quality-system vocabulary overlaps with the pharmaceutical-and-clinical-trials cluster. Regulatory-submission vocabulary overlaps with the biotechnology-and-genomics cluster. Distribution and post-market vocabulary overlaps with the healthcare-and-medical cluster. Mastering the medical-devices cluster reinforces all three.

The regulated-lifecycle cluster, organized by stage

The cluster below is grouped by what stage of the lifecycle the device is in, not by part of speech. Memorize each group as a unit, with the collocations as the unit of memorization rather than the bare lemma.

Stage 1 — design control and design history file (≈22 words)

The device is conceived. The design and development team builds a design-history file that traces every output back to a user need.

  • capture the user need in the design-input phase
  • translate the user need into a quantified design input
  • generate the design output against the design input
  • verify the design output to confirm it meets the design input
  • validate the device to confirm it meets the user need in the actual or simulated use environment
  • conduct the design review at each phase gate (concept, feasibility, development, transfer)
  • approve the design transfer to manufacturing on a documented transfer protocol
  • control the design change through a documented design-change-control procedure
  • trace the design change to the affected design-history-file element

Adjacent vocabulary: design-history file (DHF), design-input requirement, design-output deliverable, design verification protocol and report, design validation protocol and report, design transfer checklist, human factors and usability engineering (IEC 62366-1), formative usability study, summative usability study, use-related risk analysis, critical task identification, design freeze.

Stage 2 — risk management to ISO 14971 (≈20 words)

Risk management is the bone the entire regulated lifecycle is built on. ETS knows it; the cluster vocabulary recurs on every administration in this stage.

  • identify the hazard associated with the device under foreseeable use and misuse
  • estimate the risk as a product of severity and probability
  • evaluate the risk against the manufacturer's risk-acceptability criteria
  • control the risk through the inherent-safety / protective-measure / information-for-safety hierarchy
  • verify the risk control to confirm implementation and effectiveness
  • evaluate the residual risk and document the benefit-risk determination
  • disclose the residual risk in the instructions for use where required
  • review the risk management file at each design phase and at each post-market signal
  • update the risk management file on new post-market information

Adjacent vocabulary: risk-management file (RMF), risk-management plan, hazard-and-hazardous-situation table, risk-acceptability matrix, benefit-risk analysis, risk-control measure, post-production information feedback loop, harm severity scale, probability-of-occurrence scale, foreseeable misuse, reasonably foreseeable misuse, state of the art.

Stage 3 — pre-market submission and conformity assessment (≈26 words)

The device is ready to enter a regulated market. The submission pathway depends on the jurisdiction and the risk class.

  • classify the device under the applicable jurisdiction's risk-class scheme (FDA Class I/II/III, EU MDR Class I/IIa/IIb/III, IVDR Class A/B/C/D)
  • select the regulatory pathway (510(k) premarket notification, De Novo classification, premarket approval, EU MDR Annex IX or Annex X conformity assessment)
  • identify the predicate device for a 510(k) substantial-equivalence claim
  • draft the substantial-equivalence comparison across intended use, technological characteristics, and performance
  • prepare the technical documentation to MDR Annex II and Annex III (or IVDR equivalents)
  • submit the design dossier to the notified body for Annex IX conformity-assessment review
  • undergo the notified-body audit at the manufacturer's site
  • receive the EC certificate on a five-year validity with annual surveillance
  • apply the CE mark on conformity-assessment completion
  • list the device with the FDA Establishment Registration and Device Listing
  • register the device in the EU EUDAMED database

Adjacent vocabulary: 510(k) premarket notification, De Novo classification request, premarket approval (PMA), Q-submission (pre-submission meeting), IDE (investigational device exemption), GUDID (Global Unique Device Identification Database), UDI-DI and UDI-PI (unique device identification - device identifier and production identifier), SRN (single registration number, EU), PRRC (person responsible for regulatory compliance), authorized representative, importer, distributor (each MDR Article 13-14 economic operator role), notified body, competent authority, CFG (certificate to foreign government).

Stage 4 — manufacturing and quality system (≈22 words)

The device is in commercial production. The quality system runs every batch.

  • operate under 21 CFR Part 820 (FDA Quality System Regulation) or ISO 13485:2016 (international)
  • implement the quality manual across the manufacturing site
  • validate the manufacturing process on installation, operational, and performance qualification
  • verify the incoming material against the supplier-controlled material specification
  • release the device for distribution on the documented batch release authority
  • maintain the device master record (DMR) — the recipe for the device
  • maintain the device history record (DHR) — the build evidence for each batch
  • maintain the design history file (DHF) — the design evidence across the lifecycle
  • qualify the supplier on supplier audit, supplier agreement, and supplier-controlled component specification
  • control the nonconforming material through a documented nonconformance procedure

Adjacent vocabulary: IQ / OQ / PQ (installation, operational, performance qualification), IPQC (in-process quality control), CAPA (corrective and preventive action), management review (annual or more frequent), internal audit (per ISO 19011), supplier audit, supplier corrective action request (SCAR), MDSAP (Medical Device Single Audit Program covering US, Canada, Brazil, Australia, Japan), ISO 13485 certificate, cleanroom classification (ISO 14644 Class 7 or 8 typical for sterile devices), process validation master plan.

Stage 5 — post-market surveillance and vigilance (≈24 words)

The device is on the market. The manufacturer must run a post-market-surveillance system that detects signals and triggers actions.

  • operate the post-market surveillance system on the PMS plan per device
  • conduct the post-market clinical follow-up (PMCF) on the PMCF plan
  • conduct the post-market performance follow-up (PMPF) for IVD devices
  • collect the post-market signal from complaints, vigilance reports, literature surveillance, registry data, and field-service records
  • trend the post-market data on a documented periodicity
  • produce the periodic safety update report (PSUR) for MDR Class IIa, IIb, and III devices on the prescribed cadence
  • produce the post-market surveillance report (PMSR) for MDR Class I devices
  • document the field complaint on the complaint-handling procedure
  • evaluate the complaint for reportability against the jurisdictional vigilance thresholds
  • file the MDR (medical device report) with the FDA within the prescribed window (typically 30 days, 5 days for events requiring remedial action)
  • file the EU manufacturer incident report in the EUDAMED vigilance module within 2, 10, or 15 days depending on severity

Adjacent vocabulary: PMS plan, PMCF plan and report, PSUR, PMSR, trend reporting (15-day FDA, periodic-summary reporting), complaint handling (21 CFR Part 820.198), MIR (manufacturer incident report, EU), FSCA (field safety corrective action), FSN (field safety notice), serious incident, serious public-health threat, device-related death, malfunction reportability, vigilance trend, post-market signal.

Stage 6 — field action and recall (≈18 words)

A signal becomes an action. The recall vocabulary is the densest sub-cluster in the lifecycle and is tested heavily because it generates the highest volume of distributor-and-hospital email traffic.

  • initiate the field safety corrective action (FSCA) on the post-market signal
  • classify the FSCA (correction, removal, or both)
  • draft the field safety notice (FSN) for distributors and end users
  • distribute the FSN to all affected accounts
  • track the FSN acknowledgment from each account
  • quarantine the affected stock in the distribution network
  • classify the recall (FDA Class I life-threatening / Class II reversible / Class III unlikely-to-cause-adverse-effect)
  • conduct the recall effectiveness check at the prescribed sampling rate
  • terminate the recall on documented effectiveness-check completion
  • file the recall closure with the FDA District Recall Coordinator

Adjacent vocabulary: FDA Recall Enterprise System, recall strategy, recall communication plan, depth of recall (wholesale, retail, consumer/user), recall effectiveness check, market withdrawal (non-recall stock movement), stock recovery (manufacturer's own warehouse), safety alert (without product action), Dear Healthcare Provider letter, Dear Distributor letter, post-recall corrective action.

Three drills that move the cluster from passive recognition to productive command

Recognizing the words on the page is not the same as producing them under timed conditions. Three drills move the cluster across that gap.

Drill 1 — the FSCA distributor-letter dictation. Take a 220-word field-safety notice from a manufacturer's regulatory-affairs team to a European distributor (FSCA classification stated, affected lots enumerated, FSN acknowledgment deadline flagged, quarantine instructions specified, FSN-distribution-receipt-tracking requirement documented). Read it aloud once at native pace. Then reconstruct it from memory in writing within seven minutes, populating the cluster vocabulary into the correct lifecycle-stage slots.

Drill 2 — the CAPA-closure rewrite. Take a generic corrective-action closure memo and rewrite it as a medical-device CAPA closure, substituting at least twelve cluster collocations across the design control, risk management, manufacturing, and post-market stages. Verify the substituted text against the cluster list above.

Drill 3 — the 510(k) substantial-equivalence dictation. Take a 160-word email from a regulatory-affairs director to a clinical-affairs lead that explains a substantial-equivalence position against a selected predicate device. Reconstruct the email from memory in five minutes, ensuring the intended-use, technological-characteristics, and performance-comparison collocations are all deployed in the correct positions.

The eight collocations ETS recycles every test cycle

Across the past twenty-four months of TOEIC Link administrations, eight medical-devices-and-diagnostics collocations have recurred in Part 6 with disproportionate frequency. Burn these eight into productive memory before test day:

  1. trace the design output to the design input through the design-history file
  2. control the risk through the inherent-safety / protective-measure / information-for-safety hierarchy
  3. draft the substantial-equivalence comparison across intended use, technological characteristics, and performance
  4. validate the manufacturing process on installation, operational, and performance qualification
  5. release the device for distribution on the documented batch release authority
  6. evaluate the complaint for reportability against the jurisdictional vigilance thresholds
  7. initiate the field safety corrective action on the post-market signal
  8. conduct the recall effectiveness check at the prescribed sampling rate

These eight collocations are the spine of the cluster. Every other word in the 130-word inventory clips into one of these eight collocation patterns.

Where this cluster fits in the broader cluster-building program

The medical-devices-and-diagnostics cluster is one of the regulated-industry verticals in our cluster-building track. It pairs naturally with the pharmaceutical-and-clinical-trials cluster (shared GxP, regulatory-submission, and post-market-signal vocabulary), the biotechnology-and-genomics cluster (shared technology-transfer and product-development vocabulary), and the healthcare-and-medical cluster (shared hospital, distributor, and end-user vocabulary).

Treat this cluster as a single 130-word unit. Drill it as a unit. The Part 6 items that test it will not isolate words from across the lifecycle — they will write passages that move through the lifecycle from design control through risk management through submission through manufacturing through post-market surveillance through field action, and the only way to track that arc on a timed test is to have the entire cluster ready as a network of pre-committed collocations rather than as a set of independent lexical items.